Patents Assigned to TECHNOLOGIES KHLOROS INC.
  • CHEWABLE COMPOSITION FOR RAPID BUCCAL ABSORPTION
    Publication number: 20190015324
    Abstract: The present document describes a buccal delivery dosage form for administration of an active ingredient, including pharmaceutically, pharmacologically, or biologically active ingredients, in the mouth of a subject. The buccal delivery dosage form by-passes the gastrointestinal tract metabolism. The buccal delivery dosage form may comprise chemical permeation enhancers, excipients, texture modulators, and active ingredients.
    Type: Application
    Filed: September 18, 2018
    Publication date: January 17, 2019
    Applicant: Technologies Khloros Inc.
    Inventor: Marc PURCELL
  • Delivery vehicle for therapeutic gases
    Patent number: 10111903
    Abstract: The present invention relates to a buccal delivery dosage form and its use for administration of a therapeutic gas for buccal mucosal absorption of the therapeutic gas in the mouth of a subject. The buccal delivery dosage form comprises at least one crystallized excipient and at least one therapeutic gas entrapped within the crystallized excipient.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: October 30, 2018
    Assignee: TECHNOLOGIES KHLÔROS INC.
    Inventor: Marc Purcell
  • Chewable vehicle for mouth absorption
    Patent number: 10111831
    Abstract: The present document describes a buccal delivery dosage form for administration of an active ingredient, including pharmaceutically, pharmacologically, or biologically active ingredients, in the mouth of a subject. The buccal delivery dosage form by-passes the gastrointestinal tract metabolism. The buccal delivery dosage form may comprise chemical permeation enhancers, excipients, texture modulators, and active ingredients.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: October 30, 2018
    Assignee: TECHNOLOGIES KHLOROS INC.
    Inventor: Marc Purcell
  • CHEWABLE VEHICLE FOR MOUTH ABSORPTION
    Publication number: 20130337096
    Abstract: The present document describes a buccal delivery dosage form for administration of an active ingredient, including pharmaceutically, pharmacologically, or biologically active ingredients, in the mouth of a subject. The buccal delivery dosage form by-passes the gastrointestinal tract metabolism. The buccal delivery dosage form may comprise chemical permeation enhancers, excipients, texture modulators, and active ingredients.
    Type: Application
    Filed: February 28, 2012
    Publication date: December 19, 2013
    Applicant: TECHNOLOGIES KHLOROS INC.
    Inventor: Marc Purcell